Fund Name | Location |
Alphemy Capital fund | - |
BioInnovation | Cambridge, Massachusetts, United States |
BizTEC | Hefa, Hefa, Israel |
Bridge Boys | Boston, Massachusetts, United States |
Diversified Systems | Kenilworth, New Jersey, United States |
GT Healthcare Capital Partners | China, Hong Kong, Hong Kong Island |
Heron Capital | Carmel, Indiana, United States |
HSBC Securities | New York, New York, United States |
Huaruixin | China, Guangdong, Shenzhen |
Implistic Capital | Las Vegas, Nevada, United States |
Invaluable | Allston, Massachusetts, United States |
Jackson Square Ventures | California, San Francisco, United States |
Mosaix Ventures | Chicago, Illinois, United States |
Novo Nordisk Foundation | Capital Region of Denmark, Denmark, Hovedstaden |
Pidilite Industries Limited | India, Maharashtra, Mumbai |
RedMetal | Massachusetts, United States, Watertown |
St George Bank | Australia, New South Wales, Sydney |
UVM 2 Venture Investments | Central, Central Region, Singapore |
Zhonglian Investment Holdings | China, Shanghai |
zipdragon ventures | California, San Francisco, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Limula Biotech | $6M | 21 May 2024 | Lausanne, Vaud, Switzerland | ||
Testmate Health | $6M | 02 May 2024 | Vaud, Switzerland | ||
Healios AG | 30 Aug 2022 | Basel, Basel-Stadt, Switzerland | |||
MUVON Therapeutics | 31 May 2021 | Zürich, Zurich, Switzerland | |||
Microcaps | $5M | 26 Jan 2021 | Zurich, Zurich, Switzerland | ||
Synendos Therapeutics | $21M | 12 Nov 2020 | Basel-Country, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Limula Biotech | $6M | 21 May 2024 | Lausanne, Vaud, Switzerland | ||
Testmate Health | $6M | 02 May 2024 | Vaud, Switzerland | ||
Healios AG | 30 Aug 2022 | Basel, Basel-Stadt, Switzerland | |||
MUVON Therapeutics | 31 May 2021 | Zürich, Zurich, Switzerland | |||
Microcaps | $5M | 26 Jan 2021 | Zurich, Zurich, Switzerland | ||
Synendos Therapeutics | $21M | 12 Nov 2020 | Basel-Country, Switzerland |